142 related articles for article (PubMed ID: 32462973)
1. Quantitative structure-activity relationships of xanthen-3-one and xanthen-1,8-dione derivatives and design of new compounds with enhanced antiproliferative activity on HeLa cervical cancer cells.
Zukić S; Oljacic S; Nikolic K; Veljović E; Špirtović-Halilović S; Osmanović A; Završnik D
J Biomol Struct Dyn; 2021 Jul; 39(11):4026-4036. PubMed ID: 32462973
[TBL] [Abstract][Full Text] [Related]
2. Modelling of antiproliferative activity measured in HeLa cervical cancer cells in a series of xanthene derivatives.
Zukić S; Maran U
SAR QSAR Environ Res; 2020 Dec; 31(12):905-921. PubMed ID: 33236957
[TBL] [Abstract][Full Text] [Related]
3. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
4. Berberine as Source of Antiproliferative Hybrid Compounds: In Vitro Antiproliferative Activity and Quantitative Structure-activity Relationship.
Leyva-Peralta MA; Robles-Zepeda RE; Razo-Hernández RS; Berber LPÁ; Lara KO; Ruiz-Bustos E; Gálvez-Ruíz JC
Anticancer Agents Med Chem; 2019; 19(15):1820-1834. PubMed ID: 31960788
[TBL] [Abstract][Full Text] [Related]
5. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.
Ivković BM; Nikolic K; Ilić BB; Žižak ŽS; Novaković RB; Čudina OA; Vladimirov SM
Eur J Med Chem; 2013 May; 63():239-55. PubMed ID: 23501110
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
Sharma MC
Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
[TBL] [Abstract][Full Text] [Related]
7. Toward steroidal anticancer drugs: Non-parametric and 3D-QSAR modeling of 17-picolyl and 17-picolinylidene androstanes with antiproliferative activity on breast adenocarcinoma cells.
Kovačević SZ; Karadžić MŽ; Vukić DV; Vukić VR; Podunavac-Kuzmanović SO; Jevrić LR; Ajduković JJ
J Mol Graph Model; 2019 Mar; 87():240-249. PubMed ID: 30594032
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
[TBL] [Abstract][Full Text] [Related]
9. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
Sharma MC
Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
[TBL] [Abstract][Full Text] [Related]
11. Novel 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives as potent anticancer agents - Synthesis, molecular structure, QSAR studies and metabolic stability.
Pogorzelska A; Sławiński J; Żołnowska B; Szafrański K; Kawiak A; Chojnacki J; Ulenberg S; Zielińska J; Bączek T
Eur J Med Chem; 2017 Sep; 138():357-370. PubMed ID: 28688276
[TBL] [Abstract][Full Text] [Related]
12. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
13. A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design.
Noolvi MN; Patel HM; Kamboj S
Med Chem; 2012 Jul; 8(4):599-614. PubMed ID: 22530909
[TBL] [Abstract][Full Text] [Related]
14. QSAR Studies of New Pyrido[3,4-
Deokar H; Deokar M; Wang W; Zhang R; Buolamwini JK
Med Chem Res; 2018 Dec; 27(11-12):2466-2481. PubMed ID: 31360052
[TBL] [Abstract][Full Text] [Related]
15. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
16. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.
Roy K; Roy PP
Eur J Med Chem; 2009 May; 44(5):1941-51. PubMed ID: 19110342
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and Structure-activity Relationships of Naphthyridine Derivatives in Human Cervical Cancer, Leukemia, and Prostate Cancer.
Hwang YJ; Chung ML; Sohn UD; Im C
Korean J Physiol Pharmacol; 2013 Dec; 17(6):517-23. PubMed ID: 24381501
[TBL] [Abstract][Full Text] [Related]
18. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives.
Ferreira GM; Magalhães JG; Maltarollo VG; Kronenberger T; Ganesan A; Emery FDS; Trossini GHG
J Biomol Struct Dyn; 2020 Feb; 38(2):354-363. PubMed ID: 30789810
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
20. Multivariate Statistical 2D QSAR Analysis of Indenoisoquinoline-based Topoisomerase- I Inhibitors as Anti-lung Cancer Agents.
Singh S; Mangla B; Javed S; Kumar P; Ahsan W
Anticancer Agents Med Chem; 2023; 23(20):2237-2247. PubMed ID: 37807646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
